Green Fresh Biotechnology (1084) Stock Overview
An investment holding company, engages in the production of seaweed-based and plant-based hydrocolloid products in the Mainland China, Europe, rest of Asia, South America, North America, Africa, and Oceania. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
1084 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Green Fresh Biotechnology Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.74 |
| 52 Week High | HK$0.79 |
| 52 Week Low | HK$0.57 |
| Beta | -0.25 |
| 1 Month Change | 10.45% |
| 3 Month Change | 8.82% |
| 1 Year Change | 2.78% |
| 3 Year Change | -25.25% |
| 5 Year Change | -38.33% |
| Change since IPO | -45.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1084 | HK Chemicals | HK Market | |
|---|---|---|---|
| 7D | 12.1% | -3.4% | -2.9% |
| 1Y | 2.8% | 9.6% | -4.6% |
Return vs Industry: 1084 underperformed the Hong Kong Chemicals industry which returned 9.6% over the past year.
Return vs Market: 1084 exceeded the Hong Kong Market which returned -4.6% over the past year.
Price Volatility
| 1084 volatility | |
|---|---|
| 1084 Average Weekly Movement | 3.3% |
| Chemicals Industry Average Movement | 7.2% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 16.2% |
| 10% least volatile stocks in HK Market | 3.5% |
Stable Share Price: 1084 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1084's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,168 | Kam Chung Chan | www.greenfreshfood.com |
Green Fresh Biotechnology Company Limited, an investment holding company, engages in the production of seaweed-based and plant-based hydrocolloid products in the Mainland China, Europe, rest of Asia, South America, North America, Africa, and Oceania. The company operates through five segments: Manufacturing and Sales of Agar-Agar; Manufacturing and Sales of Carrageenan; Manufacturing and Sales of Konjac Products; Manufacturing and Sales of Blended Products; and Others. It offers carrageenan, agar agar, konjac gum, and flour products, as well as blended products; and solutions, including soft candy, jelly/pudding, meat product, plant-based meat product, and other applications.
Green Fresh Biotechnology Company Limited Fundamentals Summary
| 1084 fundamental statistics | |
|---|---|
| Market cap | HK$576.92m |
| Earnings (TTM) | HK$7.61m |
| Revenue (TTM) | HK$1.05b |
Is 1084 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1084 income statement (TTM) | |
|---|---|
| Revenue | CN¥904.69m |
| Cost of Revenue | CN¥737.47m |
| Gross Profit | CN¥167.23m |
| Other Expenses | CN¥160.64m |
| Earnings | CN¥6.59m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0075 |
| Gross Margin | 18.48% |
| Net Profit Margin | 0.73% |
| Debt/Equity Ratio | 69.1% |
How did 1084 perform over the long term?
See historical performance and comparisonDividends
Does 1084 pay a reliable dividends?
See 1084 dividend history and benchmarks| Green Fresh Biotechnology dividend dates | |
|---|---|
| Ex Dividend Date | Jun 16 2026 |
| Dividend Pay Date | Jul 15 2026 |
| Days until Ex dividend | 17 days |
| Days until Dividend pay date | 12 days |
Does 1084 pay a reliable dividends?
See 1084 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/02 14:19 |
| End of Day Share Price | 2026/07/02 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Green Fresh Biotechnology Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.